Pri-Med South - Primary Care CME/CE Conference & Expo

Fort Lauderdale, FL | February 9-11, 2023

Greater Ft. Lauderdale/ Broward County Convention Center

Disclosures

The following financial relationships have been disclosed by faculty, and all have been mitigated by Pri-Med Institute. Relevant relationships will be disclosed at the start of each presentation. 

Financial Disclosures

Charles E. Argoff, MD, FABPM
AbbVie, Researcher; AbbVie, Speaker; Allergan, Researcher; Amgen, Advisor; Amgen, Researcher; Amgen, Speaker; BioDelivery Sciences International, Inc., Advisor; Biohaven, Speaker; Biohaven, Speaker; Clexio Biosciences, Advisor; Collegium, Other; EnZen Therapeutics, Consultant; Lilly, Researcher; Lilly, Speaker; Lundbeck, Researcher; Neumentum, Advisor; Nevro, Advisor; Nevro, Speaker; Opioid PMR Consortium, Consultant; Redhill Pharma, Speaker; Regeneron Pharmaceuticals, Advisor; SK Life Sciences, Advisor; Teva, Researcher; Teva, Speaker; Teva Pharmaceuticals, Advisor; Tremeau Pharmaceuticals, Inc., Advisor; Vertex, Advisor; XGene Pharma, Consultant
Carly Brand Levine, MD, MPH
No relevant financial relationships disclosed.
Panagiota Caralis, MD, JD, FACP
No relevant financial relationships disclosed.
Efren Chavez Morales, MD
Information to come
Sanjiv Chopra, MD, MACP
No relevant financial relationships disclosed.
Oscar A. de Leon-Casasola, MD
Esteve Pharma, Advisor; Heron Therapeutics, Advisor; Medtronic, Advisor; Tremeau Pharma, Advisor
Juan Diaz Quinones, MD
Information to come
Peng Thim Fan, MD, FACP
AbbVie Inc., Speaker; Amgen Inc., Speaker; Pfizer Inc., Speaker; Regeneron Pharmaceuticals, Inc., Speaker; Sanofi Genzyme, Speaker
Amanda Fifi, MD
Information to come
Kristin Flanary, MA
Information to come
Will Flanary, MD
Information to come
Katherine E. Galluzzi, DO, CMD, FACOFP
No relevant financial relationships disclosed.
Ty J. Gluckman, MD, FACC, FAHA
No relevant financial relationships disclosed.
Kalpana Gupta, MD, MPH
Abbott, Stock Holder (publicly traded company); Moderna, Stock Holder (publicly traded company); Pfizer, Stock Holder (publicly traded company)
Stephen N. Henry, DO, MS
No relevant financial relationships disclosed.
Lawrence Herman, DMSc, MPA, PA-C, DFAAPA
No relevant financial relationships disclosed.
Pamela Kushner, MD, FAAFP
Abbott, Advisor; Abbott, Stock Holder (publicly traded company); AstraZeneca, Advisor; AstraZeneca, Consultant; AstraZeneca, Speaker; AstraZeneca, Stock Holder (publicly traded company); Bayer, Speaker; Boehringer Ingelheim, Advisor; Boehringer Ingelheim, Consultant; GlaxoSmithKline, Advisor; GlaxoSmithKline, Consultant; GlaxoSmithKline, Speaker; Intuity, Advisor; Janssen, Advisor; Janssen, Consultant; Lilly, Advisor; Lilly, Consultant; Lilly, Stock Holder (publicly traded company); Lilly/BI, Speaker; Novo Nordisk, Advisor; Novo Nordisk, Consultant; Pfizer, Advisor; Phathom, Advisor
Daniela Lamas, MD
Information to come
Petros Levounis, MD, MA
No relevant financial relationships disclosed.
Laura Martin, DO
Coloplast, Consultant
Bresta Y. Miranda-Palma, MD
Information to come
Jeffrey Rado, MD, MPH, FAPA
No relevant financial relationships disclosed.
Jorge Ruiz, MD
Information to come
Morgan A. Sendzischew Shane, MD
Information to come
Bhavarth Shukla, MD, MPH
No relevant financial relationships disclosed.
Charles Vega, MD, FAAFP
GlaxoSmithKline, Consultant; Johnson and Johnson, Consultant

Other Disclosures

Pamela Kushner, MD, FAAFP (Reviewer):  Advisory Board for Abbott, AstraZeneca, Janssen Pharmaceuticals, Inc., Novo Nordisk, and Pfizer. Speaker's Bureau for AstraZeneca, GlaxoSmithKline,  Janssen Pharmaceuticals, Inc., and Novo Nordisk. 

All other non-faculty contributors involved in the moderating, planning, development, editing and review of the content have disclosed no relevant financial relationships.